Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
RLJ Equity Partners is a middle-market private equity firm that invests in various sectors, including healthcare services and life sciences support. The firm typically targets companies with enterprise values between $50 million and $250 million, providing strategic capital to drive expansion and operational improvements. In the healthcare space, their portfolio has included clinical research organizations (CROs) and medical staffing firms, such as Phase One and Cross Country Healthcare. RLJ Equity Partners was founded by Robert L. Johnson in partnership with The Carlyle Group. The firm leverages its extensive network and operational expertise to create value within its portfolio companies. It is recognized as a prominent minority-owned investment firm in the United States.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on RLJ Equity Partners.